The leading source for credible citizen reporting

Report Your News
Take the tour...

Drug firms' collaboration pools HIV treatments

Source: The Independent
London : United Kingdom | about 1 month ago  
Views: 3
ViiV Healthcare, an unusual collaboration between GlaxoSmithKline and Pfizer, two of the world’s biggest drugs companies, was launched today with a mandate to pool the two firms’ HIV treatments. ViiV will inherit GSK’s agEing portfolio of HIV medicines, including Combivir, which will lose...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Times Online | about 1 month ago
    Viiv Healthcare, based in London, will have 500 employees and will focus solely on the HIV market, which has proved a tough sector for the two parent groups over the past few years. GSK, which is contributing 90 per cent of the £250 million start-up...
  • News Source: The Independent | about 1 month ago
    ViiV Healthcare, an unusual collaboration between GlaxoSmithKline and Pfizer, two of the world’s biggest drugs companies, was launched today with a mandate to pool the two firms’ HIV treatments. ViiV will inherit GSK’s agEing portfolio of HIV...
Blogs
 >
  • Blog Source: www.wtgexpert.com
    The pharmaceutical companies GlaxoSmithKline and Pfizer announced today that the joint venture created by the merger of their HIV divisions is called ViiV Healthcare. The deal was first announced in April, and aims to improve the two ...
  • Blog Source: invivoblog.blogspot.com
    The GSK/Pfizer HIV joint venture is an interesting solution to [pharma's problems of scale and funding a competitive pipeline in niche areas]. The new company is relatively small (first year projected sales: $2.4 billion); ...
Images
 >
 
Videos
 >
 
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Cell phones Cell phones use report code: @4545052

Most Popular Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.